PURPOSE: Hip arthroscopy is a well established therapeutic intervention for an increasing number of painful hip conditions. Developmental dysplasia of the hip (DDH) is commonly associated with intra-articular hip pathology. However, some surgeons perceive patients with hip dysplasia as poor candidates for hip arthroscopy. Our aim was to describe early outcomes of arthroscopic treatment for patients with DDH, who also had femoroacetabular impingement (FAI) treated when necessary, and to compare these outcomes against a control group of patients without DDH. METHODS: Prospective case-control study of 68 consecutive hip arthroscopy patients assessed with a modified Harris Hip Score (mHHS) preoperatively and at six weeks, six months, and one year after surgery. Presence of DDH was determined using a standard anteroposterior (AP) pelvic radiograph to measure the centre-edge angle (CEA) of Wiberg, with a CEA < 20º used as threshold for diagnosis of DDH. RESULTS: 12 patients (eight female and four male) with acetabular dysplasia and mean CEA of 15.4º (9º to 19º). The control, nondysplastic group comprised 54 patients (23 females and 31 males) with a mean CEA of 33.1º (22º to 45º). All patients in the dysplastic group had a labral tear and 11 (91.7%) had associated femoral cam impingement lesion addressed at arthroscopy. Our study demonstrates a significant (p=0.02) improvement in outcome in the dysplastic group at one year using the mHHS. CONCLUSION: Hip arthroscopy in the presence of DDH is effective in relieving pain for at least one year after surgery although does not address underlying acetabular abnormality.
PURPOSE: Hip arthroscopy is a well established therapeutic intervention for an increasing number of painful hip conditions. Developmental dysplasia of the hip (DDH) is commonly associated with intra-articular hip pathology. However, some surgeons perceive patients with hip dysplasia as poor candidates for hip arthroscopy. Our aim was to describe early outcomes of arthroscopic treatment for patients with DDH, who also had femoroacetabular impingement (FAI) treated when necessary, and to compare these outcomes against a control group of patients without DDH. METHODS: Prospective case-control study of 68 consecutive hip arthroscopy patients assessed with a modified Harris Hip Score (mHHS) preoperatively and at six weeks, six months, and one year after surgery. Presence of DDH was determined using a standard anteroposterior (AP) pelvic radiograph to measure the centre-edge angle (CEA) of Wiberg, with a CEA < 20º used as threshold for diagnosis of DDH. RESULTS: 12 patients (eight female and four male) with acetabular dysplasia and mean CEA of 15.4º (9º to 19º). The control, nondysplastic group comprised 54 patients (23 females and 31 males) with a mean CEA of 33.1º (22º to 45º). All patients in the dysplastic group had a labral tear and 11 (91.7%) had associated femoral cam impingement lesion addressed at arthroscopy. Our study demonstrates a significant (p=0.02) improvement in outcome in the dysplastic group at one year using the mHHS. CONCLUSION: Hip arthroscopy in the presence of DDH is effective in relieving pain for at least one year after surgery although does not address underlying acetabular abnormality.
Entities:
Keywords:
Acetabular dysplasia; femoroacetabular impingement; hip arthroscopy; outcome
Labral tears are commonly seen in patients with developmental dysplasia of the hip (DDH) [1-3], while patients with DDH are also known to present with femoroacetabular impingement (FAI) [2, 4]. Both DDH and FAI may result in abnormal loading of the acetabulum [5]. There is a claimed association between acetabular labral tears, DDH and FAI with early-onset osteoarthritis (OA) [6-15]. That said, there are no controlled trials in support of this relationship. Despite this, current orthopaedic dogma would suggest that an early diagnosis of conditions such as DDH and FAI is essential if early-onset OA is to be prevented [16-18]. Ilizaliturri et al. were first to describe arthroscopic treatment of FAI secondary to DDH [2]. The orthopaedic literature cites a few reports on hip arthroscopy in the presence of dysplasia [2, 3, 19-21]. Some surgeons perceive patients with hip dysplasia to be poor candidates for hip arthroscopy [22]. Fujii et al. in their series of 23 symptomatic dysplastic hips noted a high incidence of intraarticular lesions at hip arthroscopy performed at the time of corrective osteotomy [23]. The hip arthroscopy surgeon may choose to address such lesions and FAI lesions arthroscopically alone, without the additional significant morbidity associated with open surgery [24]. Recent advances in diagnostic imaging modalities and hiparthroscopic techniques have revealed a myriad of treatable painful hip conditions associated with hip dysplasia. These include chondral lesions [2, 3, 19, 20], ligamentum teres rupture [3, 19] and loose bodies [3, 19]. To date there is no case control study in the orthopaedic literature that describes objective outcome measures in patients with acetabular dysplasia in whom FAI has also been addressed. The aim of this study is to describe outcomes of arthroscopic treatment for patients with DDH, who also had FAI treated when necessary, and to compare these outcomes against a control group of patients without DDH.
We included a total of 66 patients in the study. Patients were divided into a dysplastic group (12 patients, eight female and four male) and a nondysplastic group (54 patients, 23 female and 31 male). A summary of the intraoperative findings is shown in Table .The mean age of patient in the dysplastic group was 40 years (19 to 50) and the mean age of the nondysplastic group was 36 years (19 to 60). There was no significant age difference between the two groups (independent samples t-test, p=0.225). The mean CEA for the dysplastic group was 15.4º (9º to 19º). The mean CEA for the nondysplastic group was 33.1º (22º to 45º).There was no significant difference (independent samples t-test) in mean total mHHS between the dysplastic and nondysplastic groups pre-operatively and at six weeks, six months and one year after surgery (Table ). There was statistically significant improvement in the mean total mHHS at one year compared with the pre-operative scores for both the dysplastic (Wilcoxon signed-rank test, p = 0.02; mean improvement 24 points) and nondysplastic (Wilcoxon signed-rank test, p <0.001; mean improvement 21 points) groups.
DISCUSSION
In 1986 Dorrell et al. [33] were the first to report on labral tears in the presence of hip dysplasia. They described degenerate labral tears as a result of abnormal stresses on the uncovered lateral portion of the femoral head and advocated surgical treatment of the labral lesion by excision, as repair was not possible in those days. They also stressed the importance of correcting the underlying morphological abnormality. By the millennium, hip arthroscopy was gaining a firm foothold in several centres around the world. In this period the first reports of hip arthroscopy in patients with dysplasia appeared in the orthopaedic literature [19, 20]. These reports predate Ganz et al’s [34] work on femoroacetabular impingement, which was to unlock the shackles of early hip arthroscopy and drive its rapid development and popularity. In their pioneering report McCarthy et al. [20] considered mainly patients with a CEA of Wiberg of between 22º and 28º. However, in their series of 170 hips 26 had a CEA of Wiberg of between16º to 22º. They described the risk of progressive repetitive trauma to the labrum and resultant risk of articular cartilage lesions because of the uncovering of the anterior femoral head. They did not describe the assessment of pain or function by way of scores, nor was FAI treated. In a second dysplasia study Byrd et al. [19] compared 16 dysplasticpatients with a CEA of Wiberg <2 0º with 32 patients who had borderline dysplasia (CEA of Wiberg 20º to 25º). For the dysplastic group they reported a mean 26-point improvement in mHHS at a mean 27-month follow-up. They also found no significant difference in preoperative and postoperative mHHS between the two groups. Byrd et al. [19] did not describe the mean CEA of Wiberg in their group of dysplasticpatients. Again, FAI was not treated. However, they concluded that hip dysplasia was not a contraindication for arthroscopy. These early studies were before the era of labral repair and FAI surgery and thus differ from our study. Our series of 12 patients with dysplasia has to our knowledge the lowest mean values for CEA of Wiberg for a hip arthroscopy publication to date.We acknowledge the short-term follow-up of this study and that our study design does not allow far comparison of outcomes between open surgery and hip arthroscopy in the presence of dysplasia.This study demonstrates hip arthroscopy in our dysplastic group to be a safe and effective procedure with favourable short-term follow-up. However, we have yet to establish if this early satisfactory outcome will translate into a better longer-term prognosis. We acknowledge that hip arthroscopy in the presence of DDH does nothing to correct the underlying morphological abnormality shown by the hip. However, it can certainly improve a patient’s pain for at least one year after surgery. Correction of the underlying bony abnormality would, of course, depend on whether or not a clear link, supported by controlled studies, exists between DDH and eventual degenerative change. This is a widely held view but currently unproven. We do agree, however, with Ilizaliturri et al. [2] that the femoral head in dysplastic hips may often need to be addressed in a timely manner to avoid irreparable damage to the hypertrophied labrum.
Table 1.
Summary of pathology found at surgery.
Pathology
Number of
Patients
(Dysplastic
Group)
Number of
Patients
(Nondysplastic
Group)
Femoroacetabular impingement
11
24
Labral tear
10
23
Osteochondral defect
4
34
Synovitis
3
8
Iliopsoas tendinopathy
2
3
Chondral delamination
1
5
Ligamentum teres tear (partial)
3
1
Table 2.
Mean total modified Harris Hip Score (mHHS) for
the dysplastic and nondysplastic groups.
Authors: M Tannast; G Zheng; C Anderegg; K Burckhardt; F Langlotz; R Ganz; K A Siebenrock Journal: Clin Orthop Relat Res Date: 2005-09 Impact factor: 4.176
Authors: Rebecca H Jessel; David Zurakowski; Christoph Zilkens; Deborah Burstein; Martha L Gray; Young-Jo Kim Journal: J Bone Joint Surg Am Date: 2009-05 Impact factor: 5.284